Related Experiment Videos
[Pathogenesis of diabetic microangiopathy]
1Istituto di Clinica Medica e Malattie Cardiovascolari Insegnamento di Metodologia Clinica, Università degli Studi di Palermo.
Minerva Endocrinologica
|June 1, 1993
Summary
Diabetic microangiopathy involves kidney and retina damage due to polyol pathway activation and nonenzymatic glycosylation. Genetic factors and hypertension also influence its severity and progression.
Area of Science:
- Endocrinology and Metabolism
- Vascular Biology
- Nephrology
Context:
- Diabetic microangiopathy pathogenesis remains incompletely understood despite recent data.
- Key affected organs include the kidney and retina.
- The condition involves complex interactions between metabolic, hemodynamic, and genetic factors.
Purpose:
- To synthesize current understanding of diabetic microangiopathy pathogenesis.
- To highlight the roles of the polyol pathway, nonenzymatic glycosylation, and vascular permeability.
- To explore the influence of genetic factors and hypertension on microvascular complications.
Summary:
- Diabetic microangiopathy pathogenesis is linked to polyol pathway activation and increased nonenzymatic glycosylation.
- Increased vascular permeability, initially hemodynamic and reversible, becomes irreversible due to vascular wall changes.
- Genetic predisposition influences microvascular damage severity, with potential links to hypertension and reduced glycosaminoglycans.
Impact:
- Provides a consolidated overview of diabetic microangiopathy mechanisms.
- Identifies key pathways and factors contributing to organ damage in diabetes.
- Suggests avenues for future research into genetic influences and therapeutic targets.